It is known that lung adenocarcinoma could be divided into several immunological subtypes, as exemplified by wound healing, IFN-gamma dominant, inflammatory, lymphocyte-depleted, immunologically quiet and TGF-beta dominant. This evidence concerns the gene IFNG and lung adenocarcinoma.